Replies to post #305083 on Anavex Life Sciences Corp (AVXL)

[poguemahone]

Not only is the full PDD data overdue at this point, but so is the ALZ full enrollment. Add to that Rett readouts, and we seem to have a backlog of data points.

I understand your frustration, but this has been an ongoing pattern over these last 5+ years. Perhaps tomorrow will yield one of the 3 above-mentioned data points.

[raja48185]

I can understand your frustration.

Based on experience (years of holding AVXL);

The AVXL Code :

Q1 most likely means Q2.

1H 2021 likely means 2H 2021

Connect the dots...safe to assume that

1H 2022 means 2H 2022

Look at the catalysts and plan accordingly (especially if you are buying call options based on milestones identified in the catalysts)

[B60611]

My main issue is that he may be withholding positive data in order to suppress the SP until he has earned milestone options (Alz full enrollment, eg). If he’s doing that, he’s a total POS. He didn’t invent the drug, and he has plenty of well below mkt options already. The one thing SAVA has over AVXL is their financial incentives are SP based so no phony baloney with withholding good news.